There are provided compounds of the formula
wherein X, Y, Z, R1, R2, R3 and R4 are as described herein
and enantiomers and pharmaceutically acceptable salts and esters thereof. The compounds are useful as anticancer agents.
There are provided compounds of the formula
wherein X, Y, Z, R
1
, R
2
, R
3
and R
4
are as described herein
and enantiomers and pharmaceutically acceptable salts and esters thereof. The compounds are useful as anticancer agents.
The present invention provides novel N-substituted fluorooxindoles having the general Formula I
wherein the wavy bond
represents the racemate, the (R)-enantiomer or the (S)-enantiomer and m, n, p, q, A, B, D, Q, X, and Z are as defined below, or a nontoxic pharmaceutically acceptable salt or solvate thereof and are useful in the treatment of disorders which are responsive to the opening of potassium channels.